Idalopirdine

DB11957InvestigationalSmall molecule

Idalopirdine has been used in trials studying the treatment of Cognition, Schizophrenia, and Alzheimer's Disease.

Mechanism: Pharmacologically active on 5-hydroxytryptamine receptor 6
Curator reviewed
Formula / weight: C₂₀H₁₉F₅N₂O · 398.377 g/mol (avg)
Code names: LU AE-58054

Resolves to

Compound

Structure

InChIKeyYBAWYTYNMZWMMJ-UHFFFAOYSA-NSMILESFC(F)C(F)(F)COC1=CC=CC(CNCCC2=CNC3=CC(F)=CC=C23)=C1

Targets

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

680Drug interactionsStructured to mechanism, not free text

10Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Idalopirdine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.